Advertisement

Extra length of stay and costs because of health care–associated infections at a German university hospital

Published:October 29, 2015DOI:https://doi.org/10.1016/j.ajic.2015.09.005

      Highlights

      • We examined extra length of stay and associated per diem costs attributable to health care–associated infections.
      • Extra length of stay was estimated by multistate modeling.
      • Health care–associated infection increased hospital length of stay and cost of care.
      • Additional costs attributable to health care–associated infections were €5,823-€11,840 ($7,453-$15,155) per infected patient.
      • Potential cost savings of at least €2 million ($2.5 million) per year were estimated for a major tertiary care center.

      Background

      Health care–associated infections (HAIs) can be associated with increased health care costs. We examined extra length of hospital stay (LOS) and associated per diem costs attributable to HAIs in a large academic medical center.

      Methods

      Data for analysis were acquired in a preinterventional phase of a prospective cohort study (ALERTS) conducted over 12 months in 27 general and 4 intensive care units at Jena University Hospital. HAIs were identified among patients hospitalized for ≥48 hours with at least 1 risk factor for HAI and new antimicrobial therapy; the diagnosis was confirmed by U.S. Centers for Disease Control and Prevention criteria. Extra LOS was estimated by multistate modeling, and associated extra costs were based on average per diem costs for clinical units sampled.

      Results

      Of a total of 22,613 patients hospitalized for ≥48 hours, 893 (3.95%) experienced 1,212 episodes of HAI during 12 months. The associated mean extra LOS ± SEM in general units was 8.45 ± 0.80 days per case and 8.09 ± 0.91 days for patients treated in both general and intensive care units. Additional costs attributable to HAIs were €5,823-€11,840 ($7,453-$15,155) per infected patient.

      Conclusion

      HAIs generated substantial extra costs by prolonging hospitalization. Potential clinical and financial savings may be realized by implementing effective infection prevention programs.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Behnke M.
        • Hansen S.
        • Leistner R.
        • Diaz L.A.
        • Gropmann A.
        • Sohr D.
        • et al.
        Nosocomial infection and antibiotic use: a second national prevalence study in Germany.
        Dtsch Arztebl Int. 2013; 110: 627-633
        • Wehner K.
        • Wrede S.
        • König T.
        • Pauletzki J.
        Ergebnisse der externen stationären Qualitätssicherung zu nosokomialen Infektionen.
        Göttingen, Germany: AQUA Institut, 2013
        • Graves N.
        Economics and preventing hospital-acquired infection.
        Emerg Infect Dis. 2004; 10: 561-566
        • Graves N.
        • Harbarth S.
        • Beyersmann J.
        • Barnett A.
        • Halton K.
        • Cooper B.
        Estimating the cost of health care-associated infections: mind your p's and q's.
        Clin Infect Dis. 2010; 50: 1017-1021
        • Beyersmann J.
        • Gastmeier P.
        • Grundmann H.
        • Bärwolff S.
        • Geffers C.
        • Behnke M.
        • et al.
        Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection.
        Infect Control Hosp Epidemiol. 2006; 27: 493-499
        • Barnett A.G.
        • Graves N.
        • Rosenthal V.D.
        • Salomao R.
        • Rangel-Frausto M.S.
        Excess length of stay due to central line-associated bloodstream infection in intensive care units in Argentina, Brazil, and Mexico.
        Infect Control Hosp Epidemiol. 2010; 31: 1106-1114
        • Barnett A.G.
        • Beyersmann J.
        • Allignol A.
        • Rosenthal V.D.
        • Graves N.
        • Wolkewitz M.
        The time-dependent bias and its effect on extra length of stay due to nosocomial infection.
        Value Health. 2011; 14: 381-386
        • Hagel S.
        • Ludewig K.
        • Frosinski J.
        • Hutagalung R.
        • Porzelius C.
        • Gastmeier P.
        • et al.
        [Effectiveness of a hospital-wide educational programme for infection control to reduce the rate of health-care associated infections and related sepsis (ALERTS)--methods and interim results].
        Dtsch Med Wochenschr. 2013; 138 ([German]): 1717-1722
        • US Food and Drug Administration
        Guidance for industry, E6 good clinical practice. Federal Register 10.
        1997 (Available from:) (Accessed July 9, 2014)
        • Food and Drug Administration
        Guidance for Industry: Part 11, Electronic Records; Electronic Signatures–Scope and Application. FDA.
        2003 (Available from:) (Accessed July 9, 2014)
        • Horan T.C.
        • Andrus M.
        • Dudeck M.A.
        CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.
        Am J Infect Control. 2008; 36: 309-332
        • Husereau D.
        • Drummond M.
        • Petrou S.
        • Carswell C.
        • Moher D.
        • Greenberg D.
        • et al.
        Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
        Value Health. 2013; 16: 231-250
        • Allignol A.
        • Schumacher M.
        • Beyersmann J.
        Estimating summary functionals in multistate models with an application to hospital infection data.
        Comput Stat. 2011; 26: 181-197
        • Wangler M.
        • Beyersmann J.
        • Schumacher M.
        changeLOS: an {R}-package for change in length of hospital stay based on the {Aalen-Johansen} estimator.
        R News. 2006; 6: 31-35
        • Allignol A.
        • Schumacher M.
        • Beyersmann J.
        Empirical transition matrix of multi-state models: the etm package.
        J Stat Softw. 2011; 38: 1-16
        • Hensen P.
        • Fürstenberg T.
        • Irps S.
        • Grabbe S.
        • Schwarz T.
        • Luger T.A.
        • et al.
        [G-DRG Version 2004: changes in view of dermatology].
        J Dtsch Dermatol Ges. 2004; 2 ([German]): 15-23
        • World Health Organization
        CHOosing Interventions that are Cost Effective (WHO-CHOICE). Country-specific unit costs.
        2008 (Available from:) (Accessed July 9, 2014)
        • Ostermann H.
        • Garau J.
        • Medina J.
        • Pascual E.
        • McBride K.
        • Blasi F.
        Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study.
        BMC Pulm Med. 2014; 14: 36-46
        • Deutsche Bundesbank Zinsstatistik
        Diskont- und Lombardsatz der Deutschen Bundesbank sowie Sonderzins bei Unterschreitung des Mindestreserve-Solls.
        2002 (Available from:) (Accessed July 9, 2014)
        • Drake P.P.
        • Fabozzi F.J.
        Foundations and applications of the time value of money.
        Hoboken, NJ: Wiley, 2009: 5-20
        • Pittet D.
        • Tarara D.
        • Wenzel R.P.
        Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
        JAMA. 1994; 271: 1598-1601
        • Kappstein I.
        • Schulgen G.
        • Beyer U.
        • Geiger K.
        • Schumacher M.
        • Daschner F.D.
        Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit.
        Eur J Clin Microbiol Infect Dis. 1992; 11: 504-508
        • Macedo-Viñas M.
        • De Angelis G.
        • Rohner P.
        • Safran E.
        • Stewardson A.
        • Fankhauser C.
        • et al.
        Burden of methicillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs.
        J Hosp Infect. 2013; 84: 132-137
        • Mitchell B.G.
        • Gardner A.
        • Barnett A.G.
        • Hiller J.E.
        • Graves N.
        The prolongation of length of stay because of Clostridium difficile infection.
        Am J Infect Control. 2014; 42: 164-167
        • Stone P.W.
        • Braccia D.
        • Larson E.
        Systematic review of economic analyses of health care-associated infections.
        Am J Infect Control. 2005; 33: 501-509
        • Scott II, R.D.
        The Direct Medical Costs of Healthcare-associated Infections in U.S. Hospitals and the Benefits of Prevention.
        Atlanta, GA: Division of Healthcare Quality Promotion National Center for Preparedness, Detection, and Control of Infectious Diseases Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention, 2009
        • Gastmeier P.
        • Brunkhorst F.
        • Schrappe M.
        • Kern W.
        • Geffers C.
        [How many nosocomial infections are avoidable?].
        Dtsch Med Wochenschr. 2010; 135 ([German]): 91-93